BDNF Val66Met polymorphism and brain volumes in multiple sclerosis

Neurological Sciences

Volumn 32, Issue 1, 2011, Pages 117-123

  Dinacci, D ^a   Tessitore, A ^a,e   Russo, A ^a   De Bonis, M L ^b   Lavorgna, L ^a   Picconi, O ^c   Sacco, R ^a   Bonavita, S ^a,e   Gallo, A ^a   Servillo, G ^a   Marcuccio, L ^a   Comerci, M ^d   Galletti, P ^a   Alfano, B ^d   Tedeschi, G ^a,e  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b REFERRAL CANCER CENTER OF BASILICATA   (Italy)

^c Opera CRO Scientific Advisor Board   (Italy)

^d CNR   (Italy)

^e Institute Hermitage Capodimonte   (Italy)

Author keywords

BDNF polymorphism; Brain atrophy; MRI; Multiple sclerosis

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; DISEASE ACTIVITY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; GRAY MATTER; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; SPECTRAL SENSITIVITY; WHITE MATTER;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; DISABILITY EVALUATION; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; METHIONINE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGRESSION ANALYSIS; VALINE; YOUNG ADULT;

EID: 79551599360     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-010-0433-z     Document Type: Article

References (61)

1. BD Trapp JW Peterson RM Ransohoff R Rudick S Mork L Bo 1998 Axonal transection in the lesions of multiple sclerosis N Engl J Med 338 278 285 1:STN:280:DyaK1c%2Fpt1SksA%3D%3D 10.1056/NEJM199801293380502 9445407
2. JW Peterson L Bo S Mork A Chang BD Trapp 2001 Transected neuritis, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions Ann Neurol 50 389 400 1:STN:280:DC%2BD3MrhtFCnug%3D%3D 10.1002/ana.1123 11558796
3. D Kidd F Barkof R McConnell PR Algra IV Allen T Revesz 1999 Cortical lesions in multiple sclerosis Brain 122 17 26 10.1093/brain/122.1.17 10050891
4. EM Frohman MK Racke CS Raine 2006 Multiple sclerosis-the plaque and its pathogenesis N Engl J Med 354 9 942 955 1:CAS:528:DC%2BD28XitVertLc%3D 10.1056/NEJMra052130 16510748
5. A Kutzelnigg CF Lucchinetti C Stadelmann W Bruck H Rauschka M Bergmann, et al. 2005 Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 Pt 11 2705 2712 10.1093/brain/awh641 16230320
6. C Bjartmar RP Kinkel G Kidd RA Rudick BD Trapp 2001 Axonal loss in normal-appearing white matter in a patient with acute MS Neurology 57 7 1248 1252 1:STN:280:DC%2BD3MrksVyhtw%3D%3D 11591844
7. R Dutta J McDonough X Yin J Peterson A Chang T Torres, et al. 2006 Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients Ann Neurol 59 3 478 489 1:CAS:528:DC%2BD28XjtV2ltr4%3D 10.1002/ana.20736 16392116
8. CF Lucchinetti W Bruck H Lassmann 2004 Evidence for pathogenic heterogeneity in multiple sclerosis Ann Neurol 56 2 308 10.1002/ana.20182 15293289
9. G Tedeschi L Lavorgna P Russo A Prinster D Dinacci G Savettieri, et al. 2005 Brain atrophy and lesion load in a large population of patients with multiple sclerosis Neurology 65 2 280 285 1:STN:280:DC%2BD2MzosFyrsw%3D%3D 10.1212/01.wnl.0000168837.87351.1f 16043800
10. N De Stefano G Iannucci MP Sormani L Guidi ML Bartolozzi G Comi, et al. 2002 MR correlates of cerebral atrophy in patients with multiple sclerosis J Neurol 249 8 1072 1077 10.1007/s00415-002-0790-5 12195457
11. N De Stefano PM Matthews M Filippi F Agosta M De Luca ML Bartolozzi, et al. 2003 Evidence of early cortical atrophy in MS: relevance to white matter changes and disability Neurology 60 7 1157 1162 12682324
12. SJ Pittock CF Lucchinetti 2007 The pathology of MS: new insights and potential clinical applications Neurologist 13 2 45 56 10.1097/01.nrl. 0000253065.31662.37 17351524 (Review)
13. Y Ge RI Grossman JK Udupa JS Babb LG Nyul DL Kolson 2001 Brain atrophy in relapsing-remitting multiple sclerosis: fractional volumetric analysis of gray matter and white matter Radiology 220 3 606 610 1:STN:280:DC%2BD3MvotlaitQ%3D%3D 10.1148/radiol.2203001776 11526256
14. RA Bermel R Bakshi 2006 The measurement and clinical relevance of brain atrophy in multiple sclerosis Lancet Neurol 5 2 158 170 10.1016/S1474-4422(06) 70349-0 16426992 (Review)
15. G Tedeschi D Dinacci M Comerci L Lavorgna G Savettieri A Quattrone, et al. 2008 Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study Mult Scler 79 11 1236 1244
16. SV Ramagopalan GC Ebers 2008 Genes for multiple sclerosis Lancet 371 9609 283 285 10.1016/S0140-6736(08)60145-2 18294983
17. GC Ebers 2008 Environmental factors and multiple sclerosis Lancet Neurol 7 3 268 277 10.1016/S1474-4422(08)70042-5 18275928
18. A Martínez R Alvarez-Lafuente A Mas M Bartolomé M García-Montojo V de Las Heras, et al. 2007 Environment-gene interaction in multiple sclerosis: human herpesvirus 6 and MHC2TA Hum Immunol 68 8 685 689 10.1016/j.humimm.2007.05.005 17678724
19. MM Poo 2001 Neurotrophins as synaptic modulators Nat Rev Neurosci 2 1 24 32 1:CAS:528:DC%2BD3MXisl2ru7s%3D 10.1038/35049004 11253356
20. M Ockel GR Lewin YA Barde 1996 In vivo effects of neurotrophin-3 during sensory neurogenesis Development 122 1 301 307 1:CAS:528:DyaK28XnvVWrtA%3D%3D 8565842
21. M Hofer SR Pagliusi A Hohn J Leibrock YA Barde 1990 Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain EMBO J 9 8 2459 2464 1:CAS:528:DyaK3cXlvVGgsro%3D 2369898
22. WJ Tyler M Alonso CR Bramham LD Pozzo-Miller 2002 From acquisition to consolidation: on the role of brain-derived neurotrophic factor signaling in hippocampal-dependent learning Learn Mem 9 5 224 237 10.1101/lm.51202 12359832
23. P Pruunsild A Kazantseva T Aid K Palm T Timmusk 2007 Dissecting the human BDNF locus: bidirectional transcription, complex splicing, and multiple promoters Genomics 90 3 397 406 1:CAS:528:DC%2BD2sXosFegsrc%3D 10.1016/j.ygeno.2007.05.004 17629449
24. CR Bramham E Messaoudi 2005 BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis Prog Neurobiol 76 2 99 125 1:CAS:528:DC%2BD2MXpvFemu7s%3D 10.1016/j.pneurobio.2005.06.003 16099088
25. XF Zhou XY Song JH Zhong S Barati FH Zhou SM Johnson 2004 Distribution and localization of probrain-derived neurotrophic factor-like immunoreactivity in the peripheral and central nervous system of the adult rat J Neurochem 91 3 704 715 1:CAS:528:DC%2BD2cXpsFelt7o%3D 10.1111/j.1471-4159.2004.02775.x 15485500
26. M Kojima N Takei T Numakawa Y Ishikawa S Suzuki T Matsumoto, et al. 2001 Biological characterization and optical imaging of brain-derived neurotrophic factor-green fluorescent protein suggest an activity-dependent local release of brain-derived neurotrophic factor in neurites of cultured hippocampal neurons J Neurosci Res 64 1 1 10 1:CAS:528:DC%2BD3MXisFWltbs%3D 10.1002/jnr.1080 11276045
27. M Kerschensteiner E Gallmeier L Behrens VV Leal T Misgeld WE Klinkert, et al. 1999 Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 189 5 865 870 1:CAS:528:DyaK1MXhsF2ju7k%3D 10.1084/jem.189.5.865 10049950
28. M Besser R Wank 1999 Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/Th2-polarized expression of their receptors J Immunol 62 11 6303 6306
29. A Braun M Lommatzsch A Mannsfeldt U Neuhaus-Steinmetz A Fischer N Schnoy, et al. 1999 Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation Am J Respir Cell Mol Biol 21 4 537 546 1:CAS:528:DyaK1MXmvFeltLk%3D 10502564
30. C Stadelmann M Kerschensteiner T Misgeld W Brück R Hohlfeld H Lassmann 2002 BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain 125 Pt 1 75 85 10.1093/brain/awf015 11834594
31. ZY Chen PD Patel G Sant CX Meng KK Teng BL Hempstead FS Lee 2004 Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons J Neurosci 24 18 4401 4411 1:CAS:528: DC%2BD2cXktFCjtLg%3D 10.1523/JNEUROSCI.0348-04.2004 15128854
32. MF Egan M Kojima JH Callicott TE Goldberg BS Kolachana A Bertolino, et al. 2003 The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function Cell 112 2 257 269 1:CAS:528:DC%2BD3sXpvVemug%3D%3D 10.1016/S0092-8674(03)00035-7 12553913
33. AJ Stern AA Savostyanova A Goldman AS Barnett JW van der Veen JH Callicott, et al. 2008 Impact of the brain-derived neurotrophic factor Val66Met polymorphism on levels of hippocampal N-acetylaspartate assessed by magnetic resonance spectroscopic imaging at 3 Tesla Biol Psychiatr 64 10 856 862 1:CAS:528:DC%2BD1cXht12gu7jI 10.1016/j.biopsych.2008.07.009
34. L Pezawas BA Verchinski VS Mattay JH Callicott BS Kolachana RE Straub, et al. 2004 The brainderived neurotrophic factor Val66Met polymorphism and variation in human cortical morphology J Neurosci 24 45 10099 10102 1:CAS:528:DC%2BD2cXhtVeqtLfK 10.1523/JNEUROSCI.2680-04.2004 15537879
35. JA Bueller M Aftab S Sen D Gomez-Hassan M Burmeister JK Zubieta 2006 BDNF Val66Met allele is associated with reduced hippocampal volume in healthy subjects Biol Psychiatr 59 9 812 815 1:CAS:528:DC%2BD28XjsFOnt78%3D 10.1016/j.biopsych.2005.09.022
36. K Nemoto T Ohnishi T Mori Y Moriguchi R Hashimoto T Asada, et al. 2006 The Val66Met polymorphism of the brain-derived neurotrophic factor gene affects age-related brain morphology Neurosci Lett 397 1-2 25 29 1:CAS:528: DC%2BD28Xit1Ois7c%3D 10.1016/j.neulet.2005.11.067 16388901
37. T Takahashi M Suzuki M Tsunoda Y Kawamura N Takahashi H Tsuneki, et al. 2008 Association between the brain-derived neurotrophic factor Val66Met polymorphism and brain morphology in a Japanese sample of schizophrenia and healthy comparisons Neurosci Lett 435 1 34 39 1:CAS:528:DC%2BD1cXktVCksbs%3D 10.1016/j.neulet.2008.02.004 18325670
38. ME Sublette E Baca-Garcia RV Parsey MA Oquendo SM Rodrigues H Galfalvy, et al. 2008 Effect of BDNF Val66Met polymorphism on age-related amygdala volume changes in healthy subjects Prog Neuropsychopharmacol Biol Psychiatr 32 7 1652 1655 1:CAS:528:DC%2BD1cXhtFartLjF 10.1016/j.pnpbp.2008.06.009
39. AR Hariri TE Goldberg VS Mattay BS Kolachana JH Callicott MF Egan DR Weinberger 2003 Brainderived neurotrophic factor Val66Met polymorphism affects human memory-related hippocampal activity and predicts memory performance J Neurosci 23 17 6690 6694 1:CAS:528:DC%2BD3sXmtFensbg%3D 12890761
40. F Miyajima W Ollier A Mayes A Jackson N Thacker P Rabbitt N Pendleton M Horan A Payton 2008 Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly Genes Brain Behav 7 4 411 417 1:CAS:528:DC%2BD1cXnvVOitro%3D 10.1111/j.1601-183X.2007.00363.x 17973920 (Epub 2007 Oct)
41. T Frodl C Schüle G Schmitt C Born T Baghai P Zill R Bottlender R Rupprecht B Bondy M Reiser HJ Möller EM Meisenzahl 2007 Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression Arch Gen Psychiatr 64 4 410 416 1:CAS:528:DC%2BD2sXltlWisrs%3D 10.1001/archpsyc.64.4.410 17404118
42. A Mirakhur TW Moorhead AC Stanfield J McKirdy JE Sussmann J Hall SM Lawrie EC Johnstone AM McIntosh 2009 Changes in gyrification over 4 years in bipolar disorder and their association with the brain-derived neurotrophic factor valine(66) methionine variant Biol Psychiatr 66 293 297 1:CAS:528:DC%2BD1MXotF2nsro%3D 10.1016/j.biopsych.2008.12.006
43. BC Ho P Milev DS O'Leary A Librant NC Andreasen TH Wassink 2006 Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers Arch Gen Psychiatr 63 7 731 740 1:CAS:528: DC%2BD28XnsFGls74%3D 10.1001/archpsyc.63.7.731 16818862
44. BC Ho NC Andreasen JD Dawson TH Wassink 2007 Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia Am J Psychiatr 164 12 1890 1899 10.1176/appi.ajp.2007.05111903 18056245
45. B Weinstock-Guttman R Zivadinov M Tamaño-Blanco N Abdelrahman D Badgett J Durfee S Hussein, et al. 2007 Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis J Neuroimmunol 188 1-2 167 174 1:CAS:528:DC%2BD2sXotlWqtbw%3D 10.1016/j.jneuroim.2007.06.003 17602759 (Epub 2007 Jun 28)
46. M Liguori F Fera A Patitucci I Manna F Condino P Valentino, et al. 2008 A longitudinal observation of brain-derived neurotrophic factor mRNA levels in patients with relapsing-remitting multiple sclerosis Brain Res 1256 123 128 10.1016/j.brainres.2008.11.047 19071096
47. R Zivadinov B Weinstock-Guttman R Benedict M Tamaño-Blanco S Hussein N Abdelrahman, et al. 2007 Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor Hum Mol Genet 16 22 2659 2668 1:CAS:528:DC%2BD2sXht1aksbjI 10.1093/hmg/ddm189 17656372 (Epub 2007 Jul 26)
48. M Liguori F Fera MC Gioia P Valentino I Manna F Condino, et al. 2007 Investigating the role of brain derived neurotrophic factor in relapsing-remitting multiple sclerosis Genes Brain Behav 6 2 177 183 1:CAS:528:DC%2BD2sXksFWls7s%3D 10.1111/j.1601-183X.2006.00245.x 16740142
49. Y Blanco M Gómez-Choco JL Arostegui B Casanova JE Martínez-Rodríguez I Boscá E Munteis J Yagüe F Graus A Saiz 2006 No association of the Val66Met polymorphism of brain-derived neurotrophic factor BDNF) to multiple sclerosis Neurosci Lett 396 3 217 219 1:CAS:528:DC%2BD28XitVCqtr8%3D 10.1016/j.neulet.2005.11.032 16356643 (Epub 2005 Dec 13)
50. S Lindquist BH Schott M Ban DA Compston S Sawcer M Sailer 2005 The BDNF-Val66Met polymorphism: implications for susceptibility to multiple sclerosis and severity of disease J Neuroimmunol 167 1-2 183 185 1:CAS:528:DC%2BD2MXpvFarsrY%3D 10.1016/j.jneuroim.2005.06.008 16046000
51. B Alfano A Brunetti M Larobina M Quarantelli E Tedeschi A Ciarmiello, et al. 2000 Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis J Magn Reson Imaging 12 799 807 1:STN:280:DC%2BD3M7htVaktA%3D%3D 10.1002/1522-2586(200012)12:6<799::AID- JMRI2>3.0.CO;2-# 11105017
52. R Lanzillo A Prinster V Scarano R Liuzzi G Coppola C Florio, et al. 2006 Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN β-1b J Neurol Sci 245 1-2 141 145 1:CAS:528:DC%2BD28Xlt1CltL4%3D 10.1016/j.jns.2005.08.023 16626758 (Epub 2006 Apr 19)
53. G Tedeschi D Dinacci L Lavorgna A Prinster G Savettieri A Quattrone, et al. 2007 Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability J Neurol Sci 263 1-2 15 19 10.1016/j.jns.2007.07.004 17673234
54. M Quarantelli A Ciarmiello VB Morra G Orefice M Larobina R Lanzillo, et al. 2003 Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load Neuroimage 18 2 360 366 10.1016/S1053-8119(02) 00018-6 12595189
55. B Alfano A Brunetti EM Covelli M Quarantelli MR Panico A Ciarmiello M Salvatore 1997 Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach Magn Reson Med 37 1 84 93 1:STN:280:DyaK2s7jtlaguw%3D%3D 10.1002/mrm.1910370113 8978636
56. B Alfano A Brunetti M Larobina M Quarantelli E Tedeschi A Ciarmiello, et al. 2000 Automated segmentation and measurement of global white matter lesion volume in patients with multiple sclerosis J Magn Reson Imaging 12 6 799 807 1:STN:280:DC%2BD3M7htVaktA%3D%3D 10.1002/1522-2586(200012)12:6<799::AID- JMRI2>3.0.CO;2-# 11105017
57. B Alfano M Quarantelli A Brunetti M Larobina EM Covelli E Tedeschi, et al. 1998 Reproducibility of intracranial volume measurement by unsupervised multispectral brain segmentation Magn Reson Med 39 3 497 499 1:STN:280:DyaK1c7lvVeksA%3D%3D 10.1002/mrm.1910390321 9498607
58. B Alfano A Brunetti EM Covelli M Quarantelli MR Panico A Ciarmiello, et al. 1997 Unsupervised, automated segmentation of the normal brain using a multispectral relaxometric magnetic resonance approach Magn Reson Med 37 84 93 1:STN:280:DyaK2s7jtlaguw%3D%3D 10.1002/mrm.1910370113 8978636
59. JF Kurtzke 1983 Rating neurological impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 1:STN:280:DyaL2c%2FktValsQ%3D%3D 6685237
60. D Pelletier K Garrison R Henry 2004 Measurement of whole-brain atrophy in multiple sclerosis J Neuroimaging 14 3 Suppl 11S 19S 10.1111/j.1552-6569.2004. tb00274.x 15228755 (Review)
61. CY Cheng CJ Hong YW Yu TJ Chen HC Wu SJ Tsai 2005 Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males Brain Res Mol Brain Res 140 1-2 86 90 1:CAS:528: DC%2BD2MXhtFSitr7N 10.1016/j.molbrainres.2005.07.008 16109452 (Epub 2005 Aug 18)